Senores Pharmaceuticals Limited — Pledging, 17-02-2026: Pledge/Unpledge

Senores Pharmaceuticals' promoter group entity, Renosen Pharmaceuticals Private Limited, has unpledged 4 lakh equity shares, representing 0.87% of the total share capital. These shares were previously held by Bajaj Finance Limited. This reduction in pledged shares is generally viewed positively by investors as it signals reduced promoter leverage and financial risk.